Search Results - "Allen, Jeffery K."

Recent Trends in the Prevalence of Crohn’s Disease and Ulcerative Colitis in a Commercially Insured US Population by Kappelman, Michael D., Moore, Kristen R., Allen, Jeffery K., Cook, Suzanne F.

“…Purpose Most US inflammatory bowel disease (IBD) epidemiology studies conducted to date have sampled small, geographically restricted populations and have not…”
Get full text

Burden of Gastrointestinal Disease in the United States: 2012 Update by Peery, Anne F, Dellon, Evan S, Lund, Jennifer, Crockett, Seth D, McGowan, Christopher E, Bulsiewicz, William J, Gangarosa, Lisa M, Thiny, Michelle T, Stizenberg, Karyn, Morgan, Douglas R, Ringel, Yehuda, Kim, Hannah P, DiBonaventura, Marco Dacosta, Carroll, Charlotte F, Allen, Jeffery K, Cook, Suzanne F, Sandler, Robert S, Kappelman, Michael D, Shaheen, Nicholas J

“…Background & Aims Gastrointestinal (GI) diseases account for substantial morbidity, mortality, and cost. Statistical analyses of the most recent data are…”
Get full text

Enrollment factors and bias of disease prevalence estimates in administrative claims data by Jensen, Elizabeth T., MPH, PhD, Cook, Suzanne F., PhD, Allen, Jeffery K., MS, Logie, John, PhD, Brookhart, Maurice Alan, PhD, Kappelman, Michael D., MD, MPH, Dellon, Evan S., MD, MPH

“…Abstract Purpose Considerations for using administrative claims data in research have not been well-described. To increase awareness of how enrollment factors…”
Get full text

Prevalence of Chronic Narcotic Use Among Children With Inflammatory Bowel Disease by Buckley, Jessie P, Cook, Suzanne F, Allen, Jeffery K, Kappelman, Michael D

“…Background & Aims Narcotic analgesics are not recommended for long-term management of pain for patients with inflammatory bowel disease (IBD), particularly…”
Get full text

HDL-C Response Variability to Niacin ER in US Adults by Christian, Jennifer B., Olson, Eric J., Allen, Jeffery K., Lowe, Kimberly A.

“…Background. Niacin is the most effective treatment currently available for raising HDL-C levels. Objective. To evaluate if gender and baseline lipid levels…”
Get full text

Prevalence and cost of medication nonadherence in Parkinson's disease: Evidence from administrative claims data by Davis, Keith L., Edin, Heather M., Allen, Jeffery K.

“…We estimated the prevalence of medication nonadherence in Parkinson's disease (PD) and the association between treatment nonadherence and healthcare costs…”
Get full text

The burden of comedication among patients with inflammatory bowel disease by Buckley, Jessie P, Kappelman, Michael D, Allen, Jeffery K, Van Meter, Susan A, Cook, Suzanne F

“…Polypharmacy is of growing concern in the chronically ill, including individuals with inflammatory bowel disease (IBD). The authors aimed to describe the…”
Get full text

Mo1119 What Is the Burden of GI Illness in the United States? It Depends on How You Ask by Jensen, Elizabeth T, Cook, Suzanne, Allen, Jeffery K, Brookhart, M. Alan, Kappelman, Michael, Dellon, Evan S

Get full text

Su1057 The Burden of Comedication Among Inflammatory Bowel Disease Patients by Buckley, Jessie P, Kappelman, Michael, Allen, Jeffery K, VanMeter, Susan A, Cook, Suzanne

Get full text

67 A Decade of Increased Gastrointestinal Endoscopy Utilization and Costs in the United States, 2000-2009 by Dellon, Evan S, Carroll, Charlotte F, Allen, Jeffery K, Cook, Suzanne, Peery, Anne F, Shaheen, Nicholas J, Kappelman, Michael

Get full text

Patterns of 6-mercaptopurine and azathioprine maintenance therapy among a cohort of commercially insured individuals diagnosed with Crohn's disease in the United States by Lund, Jennifer L, Cook, Suzanne F, Allen, Jeffery K, Carroll, Charlotte F, Kappelman, Michael D

“…Thiopurines, including 6-mercaptopurine (6-MP) and azathioprine (AZA), are the mainstay of maintenance therapy for Crohn's disease (CD). However, studies…”
Get full text